| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/4/267:00 AM | $0.11 | $0.14GAAP | +27.3% | +133% | $165.8M | $180.3M | +8.7% | +13% | |
| Q2 '26 | 8/5/267:00 AM | $0.22 | $0.30GAAP | +36.4% | +100% | $187.8M | $218.3M | +16.2% | +34% | |
| Q1 '26 | 5/6/267:00 AM | $0.10 | $0.14 | +40.0% | — | $152.2M | $156.4M | +2.8% | +7% | |
| Q4 '25 | 2/26/267:00 AM | $0.07 | $0.06 | -21.4% | +142% | $150.5M | $163.3M | +8.5% | +24% | |
| Q3 '25 | 11/3/257:00 AM | $0.08 | $0.16 | +100% | +329% | $162.2M | $159.4M | -1.8% | +36% | |
| Q2 '25 | 8/4/257:00 AM | $0.03 | $0.15 | ⚠ Check | +350% | $149.4M | $163.4M | +9.3% | +49% | |
| Q1 '25 | 5/5/257:00 AM | -$0.05 | $0.00GAAP | +100% | +100% | $127.8M | $145.5M | +13.9% | +57% |
⚠ Potential error in calculation, check manually. The two EPS figures may be on different share counts (a stock split one source has not adjusted for).
GAAP = diluted EPS as filed with the SEC. Other EPS figures are adjusted (non-GAAP), the basis analysts estimate.